Jungwirth, J.; Häring, C.; König, S.; Giebeler, L.; Doshi, H.; Brandt, C.; Deinhardt-Emmer, S.; Löffler, B.; Ehrhardt, C.
D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir. Int. J. Mol. Sci. 2022, 23, 6880.
https://doi.org/10.3390/ijms23136880
AMA Style
Jungwirth J, Häring C, König S, Giebeler L, Doshi H, Brandt C, Deinhardt-Emmer S, Löffler B, Ehrhardt C.
D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir. International Journal of Molecular Sciences. 2022; 23(13):6880.
https://doi.org/10.3390/ijms23136880
Chicago/Turabian Style
Jungwirth, Johannes, Clio Häring, Sarah König, Liane Giebeler, Heena Doshi, Christian Brandt, Stefanie Deinhardt-Emmer, Bettina Löffler, and Christina Ehrhardt.
2022. "D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir" International Journal of Molecular Sciences 23, no. 13: 6880.
https://doi.org/10.3390/ijms23136880
APA Style
Jungwirth, J., Häring, C., König, S., Giebeler, L., Doshi, H., Brandt, C., Deinhardt-Emmer, S., Löffler, B., & Ehrhardt, C.
(2022). D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir. International Journal of Molecular Sciences, 23(13), 6880.
https://doi.org/10.3390/ijms23136880
